ACE and Hypertension: Hypertension: Calcium channel blockers are considered first-line treatment for hypertension in KTRs, as they have been shown to reduce the risk of graft loss (relative risk [RR] 0.75) compared with angiotensin-converting enzyme inhibitors (ACEis) [112].